// App-Quantinova.ai

P6-07-11 : Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow

Researchers

Presenter

  • S Kasimir-Bauer

Principal Investigators

  • A-K Bittner

  • A Goebel

  • O Hoffmann

  • AJ Browne

  • M Rauner

  • LC Hofbauer

  • P Wimberger

  • R Kimmig

  • TD Rachner

Medical Centers

  • University Hospital of Essen, Essen, Germany

  • University Hospital Dresden, Dresden, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bone metastases

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cancer antigen 15-3

  • Osteoprotegerin

  • Circulating tumor cells

  • Receptor activator of nuclear factor kappa-Β ligand

  • Epithelial Cell Adhesion Molecule

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved